BACK TO ALL

SILVANA KONERMANN, PH.D.

Konermann develops and applies technologies for high-throughput transcriptional perturbations to understand the cellular and molecular pathways driving human genetic risk in neurodegenerative disease

Photo of SILVANA KONERMANN, PH.D.